Graybug Vision Funding & Investors
Baltimore, MD
Graybug Vision, Inc. operates as a pharmaceutical company. The Company develops drug delivery therapies and sustained-release compounds for the treatment of eye diseases. GrayBug Vision serves patients in the United States.
graybug.comTotal Amount Raised: $129,240,000
Graybug Vision Funding Rounds
IPO
Unknown
Series C
$80,000,000
Series C Investors
C-Bridge CapitalDeerfield Capital ManagementHatteras Venture PartnersOrbiMed AdvisorsSeries B
$44,500,000
Series B Investors
Deerfield ManagementOrbiMed AdvisorsClarus VenturesHatteras Venture PartnersDebt Financing
$750,000
Series A
$1,740,000
Series A Investors
Hatteras Venture PartnersMaryland Venture FundSeries Unknown
$750,000
Series A
$1,500,000
Series A Investors
Maryland Venture FundFrank A Bonsal
Funding info provided by Diffbot.